Tachinami H, Tomihara K, Yamada SI, Ikeda A, et al. Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab. Br J Oral Maxillofac Surg 2023;61:320-326.
PMID: 37061418